Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Amortizatization of Intangibles (2022 - 2025)

Historic Amortizatization of Intangibles for CervoMed (CRVO) over the last 4 years, with Q3 2025 value amounting to $221525.0.

  • CervoMed's Amortizatization of Intangibles fell 5422.94% to $221525.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $761200.0, marking a year-over-year increase of 2157.9%. This contributed to the annual value of $208577.0 for FY2022, which is N/A changed from last year.
  • As of Q3 2025, CervoMed's Amortizatization of Intangibles stood at $221525.0, which was down 5422.94% from $483990.0 recorded in Q3 2024.
  • CervoMed's 5-year Amortizatization of Intangibles high stood at $483990.0 for Q3 2024, and its period low was $5107.0 during Q2 2023.
  • For the 4-year period, CervoMed's Amortizatization of Intangibles averaged around $121222.1, with its median value being $63648.0 (2022).
  • The largest annual percentage gain for CervoMed's Amortizatization of Intangibles in the last 5 years was 27337.96% (2023), contrasted with its biggest fall of 8398.71% (2023).
  • CervoMed's Amortizatization of Intangibles (Quarter) stood at $86420.0 in 2022, then tumbled by 94.09% to $5107.0 in 2023, then skyrocketed by 9376.99% to $483990.0 in 2024, then tumbled by 54.23% to $221525.0 in 2025.
  • Its last three reported values are $221525.0 in Q3 2025, $483990.0 for Q3 2024, and $5107.0 during Q2 2023.